로딩 중…
지수 로딩 중…
ALTEOGEN Inc.
196170· KOSDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
₩353,500-4.33%
2026-06-19
Price Chart
ALTEOGEN Inc.-8.66%
Financials
Investment Metrics(as of 2026-06-19)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | 18.94T KRW |
| Revenue | 203.76B KRW |
| Net Income | 133.48B KRW |
| Total Assets | 729.47B KRW |
| Net Assets | 512.86B KRW |
| Employees | 154 |
| Value | |
| P/E | 141.92x |
| P/B | 36.94x |
| P/S | 92.97x |
| EV/EBITDA | 221.96x |
| FCF Yield | 0.27% |
| Profitability | |
| ROE | 26.03% |
| ROA | 18.30% |
| Op. Margin | 41.81% |
| Revenue Growth | -14.45% |
| Earnings Growth | -14.08% |
| Financial Health | |
| Debt Ratio | 142.24% |
| Total Debt | 6.65B KRW |
| FCF | 50.99B KRW |
| Cash | 42.28B KRW |
| Current Ratio | 2.41x |
| Net Debt/EBITDA | -0.42x |
| Dividend | |
| Div. Yield | 0.10% |
| Performance | |
| 1Y Return | -8.66% |
| 1M Return | -1.67% |
| From 52W High | -37.87% |
| 1Y MDD | -48.21% |
| Trading | |
| Volume | 578,141 shares |
| Foreign Own. | 14.71% |
| Per Share | |
| EPS | 2,415 KRW |
| BPS | 9,344 KRW |
Company Info
Established in 2008, Alteogen is a biopharmaceutical research, development, and sales company listed on the KOSDAQ market in 2014. The company holds and researches platform technologies including Hybrozyme™ for converting intravenous to subcutaneous injections, NexP™ for sustained-release biopharmaceuticals, and NexMab™ for next-generation antibody-drug conjugates. It aims to generate technology transfer, service, sales, and royalty revenue through licensing agreements with global multinational pharmaceutical companies. Alteogen is headquartered in Yuseong-gu, Daejeon Metropolitan City.